Why Growth Is Expected To Take Off At GlaxoSmithKline plc, Barclays PLC, Associated British Foods plc & Workspace Group PLC ORD GBP1

Royston Wild details the terrific growth potential of GlaxoSmithKline plc (LON: GSK), Barclays PLC (LON: BARC), WORKSPACE GROUP PLC ORD GBP1 (LON: WKP) and Associated British Foods plc (LON: ABF).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at four FTSE winners expected to deliver explosive earnings expansion.

GlaxoSmithKline

Thanks to the effect of enduring patent losses across key labels, GlaxoSmithKline (LSE: GSK) is not expected to see the bottom line light up any time soon. The business has seen earnings duck during four of the past five years, and another hefty decline in 2015 — this time by a colossal 20% — is currently slated. Still, I am convinced the firm represents a decent long-term play as healthcare demand across the globe surges higher.

GlaxomithKline is undergoing vast restructuring to boost its financial firepower in growth areas like HIV, vaccines, cardiovascular, immuno-inflammation and respiratory, and currently has more than three-dozen products in mid-to-late-stage development. With the next generation of earnings drivers also starting to hit the shelves, the Brentford firm is expected to see earnings tick 12% higher in 2016, driving a P/E ratio of 17.4 times for this year to a very attractive 15.8 times.

Barclays

Supported by a steady improvement in the British economy, I reckon revenues should continue to ignite at Barclays (LSE: BARC). Although the firm faces a period of uncertainty as it searches for a successor to former chief executive Antony Jenkins, there are many reasons to be bullish over the firm — for one, the bank’s rolling Transform programme is taking the hatchet to Barclays’ cost base, as well as boosting its position in the red-hot e-banking arena.

And for long-term investors, I believe that Barclays’ growing exposure to Africa — the business currently operates across 15 countries on the continent — should deliver brilliant gains as it benefits from low banking product penetration and growing wealth levels in these regions. Consequently the financial giant is expected to see earnings leap 36% and 21% in 2015 and 2016 correspondingly, resulting in ultra-low P/E readings of 11 times and 8.9 times.

Workspace Group

With demand for rental space picking up from SMEs up and down the land, I expect earnings at Workspace Group (LSE: WKP) to keep ticking higher. The London firm saw like-for-like rents accelerate 6.1% during April-June from the prior three months, and 17.8% from the corresponding period in 2014. And an occupancy rate of 90.7% in the quarter came in above Workspace’s 90% target.

The number crunchers expect Workspace to enjoy a smashing 19% earnings rise in the 12 months to March 2016, resulting in a conventionally-heady P/E multiple of 45.9 times. But this reading drops to a more palatable 39.9 times for the following period thanks to predictions of a further 14% bottom-line advance. And with the company bumping up its property portfolio — Workspace bought a further two properties in the first quarter — I believe Workspace is in great shape to deliver steady earnings expansion, helping to mitigate these heady readings.

Associated British Foods

With Associated British Foods’ (LSE: ABF) Primark stores set to hit the States in the coming months, and the brand also expanding its presence on mainland Europe, the City is convinced that earnings should explode at the London firm. The growing stampede for cheap clothing and homeware helped to push sales 13% higher during October-June, and rising retail space should drive these figures still higher — another 300,000 square feet of space is being added this year alone.

Associated British Foods is also enjoying improving conditions at its Sugar division, with reduced sugar stocks pushing prices higher and wholesale costs coming down. Although these factors are not expected to supercharge earnings immediately — a 6% earnings fall is anticipated for the 12 year ending September 2015 — a 6% rebound is expected in the following period, nudging a P/E ratio of 31.7 times to 30.4 times for 2016. While this reading is still high on paper, it could be argued that the massive growth potential of Primark in particular merits this premium.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Barclays and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Google office headquarters
Investing Articles

1 reason I like buying S&P 500 shares – and 1 reason I don’t

Will this investor try to improve his potential returns by focusing more on S&P 500 shares instead of British ones?…

Read more »

Young woman holding up three fingers
Investing Articles

3 SIPP mistakes to avoid

Our writer explains a trio of potentially costly errors he tries to avoid making when investing his SIPP, on an…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Here’s how (and why) I’d start buying shares with £25 a week

Our writer uses his investment experience and current approach to explain how he would start buying shares on a limited…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s my 5-step approach to earning passive income of £500 a month

Christopher Ruane explains the handful of steps he uses to target hundreds of pounds in passive income each month.

Read more »

Investing Articles

2 UK shares I’ve been buying this week

From a value perspective, UK shares look attractive. But two in particular have been attracting Stephen Wright’s attention over the…

Read more »

Investing Articles

A lifelong second income for just £10 a week? Here’s how!

With a simple, structured approach to buying blue-chip dividend shares at attractive prices, our writer's building a second income for…

Read more »

Investing Articles

Here’s how I’d use a £20k Stocks and Shares ISA to help build generational wealth

Discover how our writer would aim to turn a £20k Stocks and Shares ISA into a sizeable nest egg by…

Read more »